UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Yi Xie, MD, PhD

Title(s)Assistant Professor, Laboratory Medicine
SchoolSchool of Medicine
ORCID ORCID Icon0000-0002-8058-5736 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Peking University Health Science Center, Beijing, ChinaM.D.
    University of Alabama at Birmingham, Birmingham, ALPh.D.
    University of Southern California, Los Angeles, CAResidencyAnatomic and Clinical Pathology
    National Cancer Institute , Bethesda, MDFellowshipHematopathology

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lee A, Xie YL, Barry CE, Chen RY. Current and future treatments for tuberculosis. BMJ. 2020 03 02; 368:m216. PMID: 32122882.
      View in: PubMed
    2. Ronaghy A, Wang HY, Thorson JA, Medeiros LJ, Xie Y, Zhang X, Sheikh-Fayyaz S. PD-L1 and Notch1 expression in KSHV/HHV-8 and EBV associated germinotropic lymphoproliferative disorder: case report and review of the literature. Pathology. 2017 Jun; 49(4):430-435. PMID: 28450091.
      View in: PubMed
    3. Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica. 2017 02; 102(2):364-372. PMID: 27846610.
      View in: PubMed
    4. Xie Y, Vallangeon B, Liu X, Lagoo AS. Plasmacytic or lymphoplasmacytic infiltrate in lymph nodes: Diagnostic approach and differential considerations. Indian J Pathol Microbiol. 2016 Oct-Dec; 59(4):446-456. PMID: 27721273.
      View in: PubMed
    5. Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G. The genetic landscape of dural marginal zone lymphomas. Oncotarget. 2016 Jul 12; 7(28):43052-43061. PMID: 27248180.
      View in: PubMed
    6. Xie Y, Pittaluga S, Jaffe ES. The histological classification of diffuse large B-cell lymphomas. Semin Hematol. 2015 Apr; 52(2):57-66. PMID: 25805585.
      View in: PubMed
    7. Xie Y, Bulbul MA, Ji L, Inouye CM, Groshen SG, Tulpule A, O'Malley DP, Wang E, Siddiqi IN. p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study. Am J Clin Pathol. 2014 Apr; 141(4):593-604. PMID: 24619762.
      View in: PubMed
    8. Boonchalermvichian C, Xie Y, Brynes RK, Siddiqi IN. Spontaneous, transient regression of B lymphoblastic leukemia in an adult patient: a variant presentation of prodromal/pre-ALL. Leuk Res. 2012 Mar; 36(3):e57-9. PMID: 22129477.
      View in: PubMed